Cargando…
Therapeutic Prospection of Animal Venoms-Derived Antimicrobial Peptides against Infections by Multidrug-Resistant Acinetobacter baumannii: A Systematic Review of Pre-Clinical Studies
Infections caused by multidrug-resistant Acinetobacter baumannii (MDR-Ab) have become a public health emergency. Due to the small therapeutic arsenal available to treat these infections, health agencies have highlighted the importance of developing new antimicrobials against MDR-Ab. In this context,...
Autores principales: | Lima, William Gustavo, de Lima, Maria Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143903/ https://www.ncbi.nlm.nih.gov/pubmed/37104206 http://dx.doi.org/10.3390/toxins15040268 |
Ejemplares similares
-
Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2022) -
Antimicrobial and Antibiofilm Effects of Peptides from Venom of Social Wasp and Scorpion on Multidrug-Resistant Acinetobacter baumannii
por: das Neves, Rogério Coutinho, et al.
Publicado: (2019) -
An Update on the Therapeutic Potential of Antimicrobial Peptides against Acinetobacter baumannii Infections
por: Rangel, Karyne, et al.
Publicado: (2023) -
Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2021) -
In Vitro and In Vivo Antimicrobial Activity of the Novel Peptide OMN6 against Multidrug-Resistant Acinetobacter baumannii
por: Michaeli, Janna, et al.
Publicado: (2022)